Our achievements. Our accomplishments. Our impact.



  • Public Engagement

    The Stem Cell Network has elevated the level of public discourse and understanding about stem cells in Canada by engaging Canadians in artistic, accessible and innovative explorations of emerging issues in the field and by becoming an active and respected presence online.

    READ STORY

  • Catalyzing New Organizations

    The Stem Cell Network was critical for strategically identifying structural gaps in the Canadian stem cell research landscape and bringing together diverse stakeholder groups to seize those opportunities through the incubation and launch of new organizations.

    READ STORY

  • Student Engagement

    In collaboration with educators, researchers and graduate-level trainees, the Stem Cell Network has directly engaged thousands of high school students across the country to enhance their learning about various aspects of stem cell research.

    READ STORY

  • Stem Cell Plasticity

    Adult stem cells offer great potential as tools or targets of new treatments, and the Stem Cell Network launched a multidisciplinary project early in its mandate in order to discover more about the nature of these mysterious cells.

    READ STORY

  • Blood Stem Cell Expansion

    Over more than a decade of targeted funding, the Stem Cell Network harnessed the strength of world-leading Canadian researchers to develop technologies to increase quantities of blood stem cells for expanded therapeutic use and to overcome a significant hurdle in the delivery of cell-based treatments to patients.

    READ STORY

  • Commercialization

    The Stem Cell Network’s catalysis of commercialization of stem cell research has led to 399 patent applications, 60 issued patents, 43 licenses granted, the growth or launch of 11 start-up biotechnology companies and the establishment of a new Centre for the Commercialization of Regenerative Medicine (CCRM) to develop a strong industry presence in several emerging technology areas likely to be crucial to the future delivery of stem cell-based therapies.

    READ STORY